London, United Kingdom
Advent Life Sciences is an eminent venture investor with a trans-Atlantic focus, endeavoring to create pioneering Life Sciences enterprises in the USA, Europe, and the UK.
46
Total Investments
28
Portfolio Companies
-
Exits
5
Industries
General Information
Industries
Biotechnology, Digital Health +3
Funding Stage
Seed +3
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Advent Life Sciences
Recent Investments (46)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Jan 2026 | |
| Series C | •••••• | Apr 2025 | |
| Grant | •••••• | Oct 2024 | |
| Series B | •••••• | Jul 2024 | |
| Series A | •••••• | Feb 2024 | |
•••• ••••
|
Series B | •••••• | Feb 2024 |
|
•••• ••••
|
Series E | •••••• | Jan 2024 |
|
•••• ••••
|
Series A | •••••• | Oct 2022 |
|
•••• ••••
|
Venture Round - Tridek | •••••• | Sep 2022 |
|
•••• ••••
|
Series C | •••••• | Aug 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
